CMECPECNE

Novel Targeting of PCSK9 with siRNA for LDL-C Reduction in a High-Risk Population

Novel Targeting of PCSK9 with siRNA for LDL-C Reduction in a High-Risk Population

This activity is supported by educational funding provided by The Medicines Company.

Overview

CME Information

page 1 of 8